CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/19/2026
Back to search
Official data from USPTO
VIRUFLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VIRUFLEX
ST13
US500000079391419Class
5, 40, 42
Filing
79391419
Registration
7764459
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 40, 42
Filing date
12/19/2023
Registration date
04/22/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/22/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CH
Examiner
PAPALE, LISA ANNE
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
RocketVax AG
Swiss Rockets AG
Representatives
Dwayne K. Goetzel Kowert, Hood, Munyon, Rankin & Goetzel,
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for the treatment of human immune system or infectious diseases and conditions; medical and veterinary preparations namelydiagnostic preparations for medical and veterinary purposes; medical and veterinary preparations namelypreparations for the prevention and treatment of malignantinfectiousautoimmune disordersdiseasesconditions for medical and veterinary purposes; preparations for vaccines; vaccinesin particular viral vaccines; adjuvants and additives for vaccinesvaccine adjuvants and vaccine stabilizers; additives for vaccinesvaccine stabilizers
Class 40
Manufacturing and processing pharmaceutical productsmedical and veterinary preparationspreparations for vaccinesvaccinesin particular viral vaccinesadjuvants and additives for vaccines as well as adjuvants intended for use with vaccinesto order and according to customer requirements
Class 42
Scientific and technological servicesscientific analysis and testing in the field of vaccines; scientific research and design services relating to vaccines; design and development of computer software; research and development services relating to vaccines; Software as a Service (SaaS) featuring software for analyzing and engineering of viral genomes
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/08/2025
FIMP
FINAL DISPOSITION PROCESSED
11/08/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/29/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/13/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/13/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/22/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/10/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/10/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/10/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2025
RFNT
REFUSAL PROCESSED BY IB
08/31/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/14/2024
RFRR
REFUSAL PROCESSED BY MPU
08/14/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/06/2024
CNRT
NON-FINAL ACTION WRITTEN
08/05/2024
DOCK
ASSIGNED TO EXAMINER
07/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2024
Continuous trademark protection
Get notified about every new filing that threatens VIRUFLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.